bendamustine hydrochloride has been researched along with Skin Neoplasms in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 3 (30.00) | 2.80 |
| Authors | Studies |
|---|---|
| Assaf, C; Burmann, SN; Cerroni, L; Kreuter, A; Michalowitz, AL; Oellig, F | 1 |
| Diaz-Perez, J; Ingrasci, G; Romanelli, P; Verne, S; Yosipovitch, G | 1 |
| Al-Rohil, RN; Kheterpal, MK; Leckey, BD; Selim, MA | 1 |
| Baykal, C; Buyukbabani, N; Kutlay, A | 1 |
| Bagot, M; Battistella, M; Bouaziz, JD; Brice, P; de Masson, A; Delyon, J; Dumont, M; Herms, F; Lebbé, C; Madelaine, I; Moins-Teisserenc, H; Peffault de Latour, R; Ram-Wolff, C; Roelens, M | 1 |
| Carter, JB; Cohen, JM; Ferry, JA; Nazarian, RM; Takvorian, RW | 1 |
| Kwong, YL; Poon, LM | 1 |
| Franke, I; Gollnick, H; Leverkus, M; Mleczko, A; Scheinpflug, K | 1 |
| Austein, T; Demme, B | 1 |
| Keilholz, U; Schmidt-Hieber, M; Schmittel, A; Thiel, E | 1 |
1 review(s) available for bendamustine hydrochloride and Skin Neoplasms
| Article | Year |
|---|---|
Rare presentation of secondary cutaneous involvement by splenic marginal zone lymphoma: report of a case and review of the literature.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Biomarkers, Tumor; Biopsy; Female; Humans; Immunohistochemistry; Lymphoma, B-Cell, Marginal Zone; Nitrogen Mustard Compounds; Predictive Value of Tests; Remission Induction; Rituximab; Skin Neoplasms; Splenic Neoplasms; Time Factors; Treatment Outcome | 2015 |
1 trial(s) available for bendamustine hydrochloride and Skin Neoplasms
| Article | Year |
|---|---|
A phase II study of bendamustine chemotherapy as second-line treatment in metastatic uveal melanoma.
Topics: Adult; Aged; Antineoplastic Agents; Bendamustine Hydrochloride; Female; Humans; Infusions, Intravenous; Male; Melanoma; Middle Aged; Neoplasm Staging; Nitrogen Mustard Compounds; Salvage Therapy; Skin Neoplasms; Survival Rate; Treatment Outcome; Uveal Neoplasms | 2004 |
8 other study(ies) available for bendamustine hydrochloride and Skin Neoplasms
| Article | Year |
|---|---|
Bendamustine monochemotherapy in aggressive or advanced-stage primary cutaneous T-cell lymphomas.
Topics: Bendamustine Hydrochloride; Humans; Lymphoma, T-Cell, Cutaneous; Skin Neoplasms | 2023 |
Cutaneous Presentation of T-Cell Prolymphocytic Leukemia Mimicking Dermatomyositis.
Topics: Alemtuzumab; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Biomarkers, Tumor; Biopsy; Dermatomyositis; Diagnosis, Differential; Female; Humans; Leukemia, Prolymphocytic, T-Cell; Middle Aged; Predictive Value of Tests; Skin Neoplasms; Stem Cell Transplantation; Treatment Outcome | 2021 |
Cutaneous involvement by T-cell prolymphocytic leukemia presenting as livedoid vasculopathy.
Topics: Aged; Alemtuzumab; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Immunological; Bendamustine Hydrochloride; Biopsy; Diagnosis, Differential; Disease Progression; Exanthema; Extremities; Fatal Outcome; Humans; Hyperpigmentation; Immunohistochemistry; Leukemia, Prolymphocytic, T-Cell; Male; Skin Neoplasms; Torso; Vascular Diseases | 2021 |
Complete healing of basal cell carcinoma under bendamustine and brentuximab vedotin therapy in a patient with cutaneous lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Brentuximab Vedotin; Carcinoma, Basal Cell; Humans; Lymphoma, Primary Cutaneous Anaplastic Large Cell; Male; Middle Aged; Skin Neoplasms; Treatment Outcome | 2019 |
Efficacy and safety of brentuximab vedotin plus bendamustine in advanced-stage primary cutaneous T-cell lymphomas.
Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Brentuximab Vedotin; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Neoplasm Staging; Pneumonia, Pneumocystis; Severity of Illness Index; Skin; Skin Neoplasms; Treatment Outcome | 2019 |
Complete remission of refractory disseminated NK/T cell lymphoma with brentuximab vedotin and bendamustine.
Topics: Adolescent; Allografts; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Brentuximab Vedotin; Combined Modality Therapy; Drug Resistance, Neoplasm; Epstein-Barr Virus Infections; Female; Hematopoietic Stem Cell Transplantation; Herpesvirus 4, Human; Humans; Immunoconjugates; Immunophenotyping; Ki-1 Antigen; Lymphoma, Extranodal NK-T-Cell; Lymphoma, Primary Cutaneous Anaplastic Large Cell; Remission Induction; RNA, Viral; Salvage Therapy; Skin Neoplasms; Tumor Virus Infections | 2016 |
Intravascular large B-cell lymphoma: successful therapy with bendamustine and rituximab.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Bendamustine Hydrochloride; Blood Vessels; Drug Therapy, Combination; Female; Humans; Lymphocytes; Lymphoma, B-Cell; Nitrogen Mustard Compounds; Remission Induction; Rituximab; Skin Neoplasms | 2009 |
Uncommon recurrence of follicular lymphoma.
Topics: Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Head and Neck Neoplasms; Humans; Lymphoma, Follicular; Male; Nitrogen Mustard Compounds; Prednisone; Remission Induction; Rituximab; Skin Neoplasms | 2012 |